New pain shot could cut opioid use after eye removal
NCT ID NCT02381353
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a standard painkiller (bupivacaine) to a slow-release version (Exparel) for pain after eye removal surgery. 88 adults having their eye removed at Mayo Clinic will receive one of the two injections during surgery. The goal is to see if the slow-release drug provides better pain control for up to 3 days and reduces the need for oral narcotics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
University of Michigan Kellogg Eye Institute
Ann Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Can a simple pill speed up knee replacement recovery?
- A pinprick test may forecast severe pain after C-Section
- Smartphone video may read pain in a Patient's face
- Which nerve drug wins the battle against Post-Surgical knee pain?
- Could a VR headset replace pills for surgery anxiety?